Melco Resorts & Entertainment Ltd
Change company Symbol lookup
Select an option...
MLCO Melco Resorts & Entertainment Ltd
WMT WALMART STORES INC
DX Dynex Capital Inc
BMO Bank of Montreal
FPRX Five Prime Therapeutics Inc
VTR Ventas Inc
PENN Penn National Gaming Inc
SUN Sunoco LP
SWKS Skyworks Solutions Inc
VOO Vanguard S&P 500 ETF
Go

Consumer Discretionary : Hotels, Restaurants & Leisure |
Based in Hong Kong
Company profile

Melco Resorts & Entertainment Limited, formerly Melco Crown Entertainment Limited, is a holding company. The Company, through its subsidiaries, develops, owns and operates casino gaming and entertainment casino resort facilities in Asia. It is principally engaged in the gaming and hospitality business in Asia and its principal operating and developmental activities occur in over two geographic areas, which include Macau and the Philippines. Its segments include City of Dreams, Altira Macau, Studio City, Mocha Clubs, City of Dreams Manila, and Corporate and Others. It has over three casino based operations in Macau, namely, City of Dreams, Altira Macau and Studio City, and non-casino based operations in Macau at its Mocha Clubs. It also has a casino based operation in the Philippines, City of Dreams Manila. It is developing the fifth hotel tower at City of Dreams in Cotai, Macau. Its other operations also include Taipa Square Casino, Macau operating within Hotel Taipa Square.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$14.94
Day's Change
0.31 (2.12%)
Bid
--
Ask
--
B/A Size
--
Day's High
15.14
Day's Low
14.57
Volume
(Average)
Volume:
3,032,350

10-day average volume:
3,145,804
3,032,350

Worldwide Risk-based Monitoring Software Industry to 2026 - Featuring MasterControl, Veeva Systems & Techso Among Others - ResearchAndMarkets.com

8:05 am ET September 18, 2020 (BusinessWire) Print

The "Global Risk-based Monitoring Software Market Analysis 2020" report has been added to ResearchAndMarkets.com's offering.

The Global Risk-based Monitoring Software market is expected to reach $652.40 million by 2026 growing at a CAGR of 15.3% from 2019 to 2026.

Risk-based monitoring (RBM) software is a clinical trial-monitoring method that fulfills regulatory necessities. It employs various tools, platforms and dashboards to identify signals, which indicate potential issues with trial conduct, safety, data integrity, compliance and enrollment.

Factors such as the growing number of outsourcing activities of clinical trials to CROs and increasing usages of software for the rising number of clinical trials are driving the growth of the market. However, the high implementation cost is restraining the growth of the market.

Based on the component, the software segment is anticipated to grow at a significant rate during the forecast period owing to increasing R&D expenditure in the life science and clinical research industries, an increasing number of clinical trials, and rising customer base.

The key vendors mentioned are MasterControl, Veeva Systems, Techsol Corporation, Parexel, Oracle, ArisGlobal, MedNet Solutions, Bio-Optronics, MaxisIT, Covance, IBM Corporation, Forte Research Systems, ERT, DSG, OpenClinica, CRF Health, Anju Software, DATATRAK, Bioclinica, and Medidata Solutions.

Key Questions Answered in this Report:

How this market evolved since the year 2018 Market size estimations, forecasts and CAGR for all the segments presented in the scope Key Market Developments and financials of the key players Opportunity Analysis for the new entrants SWOT Analysis of the key players Fastest growing markets analyzed during the forecast period

Key Topics Covered:

1 Market Synopsis

2 Research Outline

2.1 Research Snapshot

2.2 Research Methodology

2.3 Research Sources

2.3.1 Primary Research Sources

2.3.2 Secondary Research Sources

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Risk-based Monitoring Software Market, By Component

5.1 Introduction

5.2 Software

5.3 Services

6 Global Risk-based Monitoring Software Market, By Type

6.1 Introduction

6.2 Site RBM Software

6.3 Enterprise RBM Software

7 Global Risk-based Monitoring Software Market, By Application

7.1 Introduction

7.2 Medical Equipment

7.3 Clinical Trials

7.4 Biopharmaceutical

8 Global Risk-based Monitoring Software Market, By Delivery Mode

8.1 Introduction

8.2 Web-based (On-demand)

8.3 Licensed Enterprise (On-premise)

8.4 Cloud-based (SaaS)

9 Global Risk-based Monitoring Software Market, By End User

9.1 Introduction

9.2 Pharmaceutical & Biopharmaceutical Companies

9.3 Medical Device Companies

9.4 Contract Research Organizations (CROs)

10 Global Risk-based Monitoring Software Market, By Geography

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia Pacific

10.5 South America

10.6 Middle East & Africa

11 Strategic Benchmarking

12 Vendors Landscape

12.1 MasterControl

12.2 Veeva Systems

12.3 Techsol Corporation

12.4 Parexel

12.5 Oracle

12.6 ArisGlobal

12.7 MedNet Solutions

12.8 Bio-Optronics

12.9 MaxisIT

12.10 Covance

12.11 IBM Corporation

12.12 Forte Research Systems

12.13 OpenClinica

12.14 CRF Health

12.15 Anju Software

12.16 DATATRAK

12.17 Bioclinica

12.18 Medidata Solutions

For more information about this report visit https://www.researchandmarkets.com/r/jq07pt

View source version on businesswire.com: https://www.businesswire.com/news/home/20200918005279/en/

SOURCE: Research and Markets

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com 
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.